Pictet Asset Management Holding SA Sells 98,389 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Pictet Asset Management Holding SA lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 75.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 32,504 shares of the company’s stock after selling 98,389 shares during the period. Pictet Asset Management Holding SA’s holdings in Bath & Body Works were worth $1,260,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new position in shares of Bath & Body Works during the fourth quarter worth about $26,000. SRS Capital Advisors Inc. grew its stake in shares of Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC lifted its position in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works during the third quarter worth $39,000. 95.14% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have issued reports on BBWI shares. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Piper Sandler upped their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Telsey Advisory Group reissued an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Raymond James reissued an “outperform” rating and set a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.06.

Get Our Latest Research Report on Bath & Body Works

Bath & Body Works Stock Down 2.6 %

Bath & Body Works stock opened at $27.11 on Friday. The stock has a market cap of $5.81 billion, a PE ratio of 6.61, a P/E/G ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 12-month low of $25.41 and a 12-month high of $52.99. The business’s 50-day moving average price is $34.45 and its two-hundred day moving average price is $34.13.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. As a group, analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.95%. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Bath & Body Works declared that its board has initiated a stock buyback plan on Thursday, February 27th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.